CTSO (STOCKS)
Cytosorbents Corp.
$0.449700
+0.049900 (+12.48%)
Prev close: $0.399800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Phillip P. Chan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $28.06M
- Employees
- 149
- P/E (TTM)
- -2.10
- P/B (TTM)
- 11.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.08 | $-0.06 | -0.0239 | -42.60% |
|
Dec 2025 (Q4)
|
$-0.09 | $-0.05 | -0.0390 | -76.47% |
|
Sep 2025 (Q3)
|
$-0.05 | $-0.05 | -0.0024 | -5.04% |
|
Jun 2025 (Q2)
|
$0.03 | $-0.05 | +0.0810 | +158.82% |
Financial Statements
| Revenues | $37.20M |
| Benefits Costs and Expenses | $41.78M |
| Cost Of Revenue | $10.79M |
| Costs And Expenses | $55.01M |
| Gross Profit | $26.41M |
| Nonoperating Income/Loss | $1.66M |
| Operating Expenses | $40.32M |
| Selling, General, and Administrative Expenses | $35.36M |
| Operating Income/Loss | -$13.91M |
| Income/Loss From Continuing Operations After Tax | -$11.85M |
| Income/Loss From Continuing Operations Before Tax | -$4.58M |
| Income Tax Expense/Benefit | -$401.00K |
| Net Income/Loss | -$11.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.19 |
| Diluted Earnings Per Share | -$0.19 |
| Basic Average Shares | 188,294,253 |
| Diluted Average Shares | 192,852,032 |
| Assets | $40.56M |
| Current Assets | $17.76M |
| Inventory | $4.48M |
| Other Current Assets | $13.28M |
| Noncurrent Assets | $22.81M |
| Fixed Assets | $7.51M |
| Other Non-current Assets | $15.30M |
| Liabilities | $38.37M |
| Current Liabilities | $16.30M |
| Accounts Payable | $3.13M |
| Other Current Liabilities | $13.17M |
| Noncurrent Liabilities | $22.07M |
| Long-term Debt | $16.96M |
| Other Non-current Liabilities | $5.11M |
| Equity | $2.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.19M |
| Liabilities And Equity | $40.56M |
| Net Cash Flow From Operating Activities | -$10.07M |
| Net Cash Flow From Operating Activities, Continuing | -$10.07M |
| Net Cash Flow From Investing Activities | -$414.00K |
| Net Cash Flow From Investing Activities, Continuing | -$414.00K |
| Net Cash Flow From Financing Activities | $3.69M |
| Net Cash Flow From Financing Activities, Continuing | $3.69M |
| Net Cash Flow | -$6.80M |
| Net Cash Flow, Continuing | -$6.80M |
| Comprehensive Income/Loss | -$15.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.47M |
| Other Comprehensive Income/Loss | -$3.62M |